{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:40:02Z","timestamp":1782351602256,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ajem.2018.08.048","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T23:23:00Z","timestamp":1534548180000},"page":"1060-1064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical effects of reported synthetic cannabinoid exposure in patients admitted to the intensive care unit"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3971-7191","authenticated-orcid":false,"given":"Michael","family":"Tatusov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Mazer-Amirshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleeza","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munish","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2018.08.048_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMp1505328","article-title":"Synthetic cannabinoid-related illnesses and deaths","volume":"373","author":"Trecki","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2018.08.048_bb0010","first-page":"542490","article-title":"The wide and unpredictable scope of synthetic cannabinoids toxicity","volume":"2015","author":"Orsini","year":"2015","journal-title":"Case Rep Crit Care"},{"issue":"1","key":"10.1016\/j.ajem.2018.08.048_bb0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s13181-011-0182-2","article-title":"Convulsions associated with the use of a synthetic cannabinoid product","volume":"8","author":"Schneir","year":"2012","journal-title":"J Med Toxicol"},{"issue":"4","key":"10.1016\/j.ajem.2018.08.048_bb0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hup.2292","article-title":"The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products","volume":"28","author":"Winstock","year":"2013","journal-title":"Hum Psychopharmacol"},{"issue":"4","key":"10.1016\/j.ajem.2018.08.048_bb0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13181-016-0558-4","article-title":"Clinical effects of synthetic cannabinoid receptor agonists compared with marijuana in emergency department patients with acute drug overdose","volume":"12","author":"Zaurova","year":"2016","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.ajem.2018.08.048_bb0035","author":"Serogroup"},{"key":"10.1016\/j.ajem.2018.08.048_bb0040","article-title":"Acute effects of synthetic cannabinoids: update 2015","volume":"0","author":"Tournebize","year":"2016","journal-title":"Subst Abus"},{"issue":"3","key":"10.1016\/j.ajem.2018.08.048_bb0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5811\/westjem.2016.2.29519","article-title":"Case series of synthetic cannabinoid intoxication from one toxicology center","volume":"17","author":"Katz","year":"2016","journal-title":"West J Emerg Med"},{"issue":"8","key":"10.1016\/j.ajem.2018.08.048_bb0050","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1212\/01.wnl.0000453555.25241.99","article-title":"Ischemic stroke after use of the synthetic marijuana \u201cspice\u201d","volume":"83","author":"Freeman","year":"2014","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ajem.2018.08.048_bb0055","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/imj.12521","article-title":"Sudden cardiac death complicating acute myocardial infarction following synthetic cannabinoid use","volume":"44","author":"Tse","year":"2014","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.ajem.2018.08.048_bb0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jemermed.2015.10.009","article-title":"Synthetic cannabinoids and their effects on the cardiovascular system","volume":"50","author":"Von Der Haar","year":"2016","journal-title":"J Emerg Med"},{"issue":"7","key":"10.1016\/j.ajem.2018.08.048_bb0065","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/15563650.2014.932365","article-title":"Acute kidney injury associated with smoking synthetic cannabinoid","volume":"52","author":"Buser","year":"2014","journal-title":"J Am Acad Clin Toxicol"},{"issue":"5","key":"10.1016\/j.ajem.2018.08.048_bb0070","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/00952990.2016.1176177","article-title":"A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan","volume":"42","author":"Kamijo","year":"2016","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.ajem.2018.08.048_bb0075","doi-asserted-by":"crossref","first-page":"584","DOI":"10.12659\/AJCR.891399","article-title":"Spice\/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine","volume":"15","author":"Sheikh","year":"2014","journal-title":"Am J Case Rep"},{"issue":"7","key":"10.1016\/j.ajem.2018.08.048_bb0080","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.ajem.2018.08.048_bb0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jat\/bkt062","article-title":"Identification of novel third-generation synthetic cannabinoids in products by ultra-performance liquid chromatography and time-of-flight mass spectrometry","volume":"37","author":"Shanks","year":"2013","journal-title":"J Anal Toxicol"},{"issue":"3","key":"10.1016\/j.ajem.2018.08.048_bb0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.115.225326","article-title":"AB-CHMINACA, AB-PINACA, and FUBIMINA: affinity and potency of novel synthetic cannabinoids in producing \u03949-tetrahydrocannabinol-like effects in mice","volume":"354","author":"Wiley","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajem.2018.08.048_bb0095","doi-asserted-by":"crossref","first-page":"692","DOI":"10.15585\/mmwr.mm6527a2","article-title":"Acute poisonings from synthetic cannabinoids-50 U.S. toxicology investigators consortium registry sites, 2010\u20131015","volume":"65","author":"Reider","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajem.2018.08.048_bb0100","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1360-0443.2012.04078.x","article-title":"Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings","volume":"108","author":"Hermanns-Clausen","year":"2013","journal-title":"Addiction"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675718306867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675718306867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:42:59Z","timestamp":1760024579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675718306867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0735675718306867"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2018.08.048","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical effects of reported synthetic cannabinoid exposure in patients admitted to the intensive care unit","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2018.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}